reactions have been shown to be a highly efficient ap-
proach for obtaining tetrahydropyran derivatives.6,7 For
example, both cis- and trans-2,6-disubstituted tetrahydro-
pyran derivatives, which are among the most abundant
motifs in natural products, have been synthesized this way.6,7
these catalysts led to the formation of the carba-Michael
product 2 only.2b,8 No formation of the desired oxa-
Michael product was observed probably because in com-
pound 1a the CÀH bond is more acidic than the OÀH
bond. Most recently Fuwa and co-workers have reported
that camphorsulfonic acid (CSA) (Figure 1) is a highly syn-
selective catalyst for oxa-Michael reactions of 7-oxo-hept-
5-enol derivatives.7 We then evaluated CSA as a catalyst
for cyclizing compound 1a. Indeed, with CSA as the
catalyst, the intramolecular oxa-Michael reaction gave
the expected 2,6-disubstituted 3a (R = Ph) (Scheme 1) as
a single diastereomer in a high yield. The relative stereo-
chemistry of this product was determined to be cis by NOE
experiments, which is also in agreement with the reported
syn-selectivity.7 Unfortunately, 3a was obtained as a race-
mic product using this protocol (data not shown). None-
theless, according to the reported mechanism,7 if an
optically enriched 1a is used as the substrate, then product
3a should be obtained in optically enriched form. Thus, we
screened several catalysts to obtain compound 1a in high
optical purity from enal 6a and nitromethane. Again many
basic catalysts reported for Henry reactions failed to
produce 1a as the reactions went further to form com-
pound 2 directly (data not shown). Gratifyingly, both
Ooi’s precatalyst 4 (Figure 1) in the presence of t-BuOK10
and Cu(OAc)2 in the presence of Wan’s ligands (5 and ent-5)
(Figure 1)11 gave 1a in good yields under their respective
optimized conditions.10,11 The (S)-enantiomer of compound
1a was obtained in 55% ee with 4/t-BuOK (Scheme 2, eq 3).
In contrast, with Wan’s catalytic system, both the (R)- and
(S)-enantiomers were obtained in a high ee value of 98%
using the enantiomeric ligands 5 and ent-5, respectively
(Scheme 2, eqs 4 and 5). With the optically enriched 1a in
hand, the CSA-catalyzed oxa-Michael reaction was con-
ducted again, and product 3a was obtained as a single
diastereomer in 90% yield with complete retention of the
optical purity (Scheme 2, eq 6). The enantiomer of 3a may be
similarly obtained by using (S)-1a as the starting material.
Scheme 1. Henry Product 1 May Be Used As an Ambident
Nucleophile in Intramolecular Michael Reactions
Using a one-pot sequential catalysis, we recently devel-
oped a highly stereoselective synthesis of trisubstituted
cyclohexane derivatives 2 from nitromethane and 7-oxo-
hept-5-enals involving the Henry product 1 as the inter-
mediate (Scheme 1).2b A base-catalyzed intramolecular
carba-Michael reaction leads to the formation of the
cyclohexane derivatives 2 (Scheme 1, eq 1).2b,8 During this
study, we envisioned that compound 1 may be used as an
ambident nucleophile in catalysis: An intramolecular oxa-
Michael reaction using the hydoxy group in compound 1
as a nucleophile should lead to the formation of 2,6-
disubstituted tetrahydropyrans 3 (Scheme 1, eq 2). Devel-
oping stereoselective synthesis of pyran derivatives has
been our ongoing research interest,9 and therefore, we
sought methods to conduct a stereoselective oxa-Michael
reaction on compound 1. Herein we wish to report a highly
diastereo- and enantioselective synthesis of cis-2,6-disubsti-
tuted tetrahydropyrans using a one-pot sequential catalysis.
Using the racemic Henry product 1a (R = Ph)
(Scheme 1) as the model substrate, we first attempted the
oxa-Michael using different base catalysts; however, all
(6) For some selected recent examples, see: (a) Lee, K.; Kim, H.;
Hong, J. Eur. J. Org. Chem. 2012, 1025–1032. (b) Byeon, S. R.; Park, H.;
ꢀ~
´
ez, D.; Nunez,
Kim, H.; Hong, J. Org. Lett. 2011, 13, 5816–5819. (c) Dı
ꢀ
M. G.; Beneitez, A.; Moro, R. F.; Marcos, I. S.; Basabe, P.; Broughton,
H. B.; Urones, J. G. Synlett 2009, 390. (d) Farmer, R. L.; Biddle, M. M.;
Nibbs, A. E.; Huang, X.; Bergan, R. C.; Scheidt, K. A. ACS Med. Chem.
Lett. 2010, 1, 400–405. (e) Hong, B.-C.; Kotame, P.; Tsai, C.-W.; Liao,
J.-H. Org. Lett. 2010, 12, 776–779. (f) Massi, A.; Nuzzi, A.; Dondoni, A.
€
J. Org. Chem. 2007, 72, 10279–10282. (g) Pellicena, M.; Kramer, K.;
Romea, P.; Urpı, F. Org. Lett. 2011, 13, 5350–5353. (h) Wang, L.; Li, P.;
´
Menche, D. Angew. Chem., Int. Ed. 2010, 49, 9270–9273. (i) Fuwa, H.;
Saito, A.; Sasaki, M. Angew. Chem., Int. Ed. 2010, 49, 3041–3044. (j)
Hajare, A. K.; Ravikumar, V.; Khaleel, S.; Bhuniya, D.; Reddy, D. S.
J. Org. Chem. 2010, 76, 963–966. (k) Xie, J.-H.; Guo, L.-C.; Yang, X.-H.;
Wang, L.-X.; Zhou, Q.-L. Org. Lett. 2012, 14, 4758–4761. (l) McGarraugh,
P. G.;Brenner-Moyer, S. E.Org. Lett. 2011, 13, 6460–6463. (m) Lee, K.; Kim,
H.; Hong, J. Org. Lett. 2011, 13, 2722–2725.
(7) (a) Fuwa, H.; Ichinokawa, N.; Noto, K.; Sasaki, M. J. Org. Chem.
2011, 77, 2588–2607. (b) Fuwa, H.; Noto, K.; Sasaki, M. Org. Lett. 2011,
13, 1820–1823.
(8) Dai, Q.;Huang, H.;Zhao, J. C.-G. J. Org. Chem. 2013, 78, 4153–4157.
(9) (a) Ding, D.; Zhao, C.-G. Tetrahedron Lett. 2010, 51, 1322–1325.
(b) Gogoi, S.; Zhao, C.-G. Tetrahedron Lett. 2009, 50, 2252–2255. (c)
Muramulla, S.; Zhao, C.-G. Tetrahedron Lett. 2011, 52, 3905–3908. (d)
Ramireddy, N.; Abbaraju, S.; Zhao, C.-G. Tetrahedron Lett. 2011, 52,
6792–6795.
Figure 1. Structure of the catalyst and ligands used in this study
(Ar = p-CF3C6H4-).
(10) Uraguchi, D.; Sakaki, S.; Ooi, T. J. Am. Chem. Soc. 2007, 129,
12392–12393.
Org. Lett., Vol. 15, No. 12, 2013
2923